The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries
Open accessAbstract
High-throughput screening (HTS) of chemical compounds to identify modulators of molecular targets is a mainstay of pharmaceutical development. Increasingly, HTS is being used to identify chemical probes of gene, pathway, and cell functions, with the ultimate goal of comprehensively delineating relationships between chemical structures and biological activities. Achieving this goal will require methodologies that efficiently generate pharmacological data from the primary screen and reliably profile the range of biological activities associated with large chemical libraries. Traditional HTS, which tests compounds at a single concentration, is not suited to this task, because HTS is burdened by frequent false positives and false negatives and requires extensive follow-up testing. We have developed a paradigm, quantitative HTS (qHTS), tested with the enzyme pyruvate kinase, to generate concentration–response curves for >60,000 compounds in a single experiment. We show that this method is precise, refractory to variations in sample preparation, and identifies compounds with a wide range of activities. Concentration–response curves were classified to rapidly identify pyruvate kinase activators and inhibitors with a variety of potencies and efficacies and elucidate structure–activity relationships directly from the primary screen. Comparison of qHTS with traditional single-concentration HTS revealed a high prevalence of false negatives in the single-point screen. This study demonstrates the feasibility of qHTS for accurately profiling every compound in large chemical libraries (>10 5 compounds). qHTS produces rich data sets that can be immediately mined for reliable biological activities, thereby providing a platform for chemical genomics and accelerating the identification of leads for drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Enzyme kinetics; behavior and analysis of rapid equilibrium and steady state enzyme systems
(1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90021-3 · Cited by 2,972
The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves
Hill, A. V., Hill, A. L., & Hill, A. V. (1910) · The Journal of Physiology · Cited by 2,181
Crystal structure of the Src family tyrosine kinase Hck
Sicheri, F., Moarefi, I., & Kuriyan, J. (1997) · Nature · doi:10.1038/385602a0 · Cited by 1,172
Statistical practice in high-throughput screening data analysis
Malo, N., Hanley, J. A., Cerquozzi, S., Pelletier, J., & Nadon, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1186 · Cited by 721
Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510
NIH Molecular Libraries Initiative
Austin, C. P., Brady, L. S., Insel, T. R., & Collins, F. S. (2004) · Science · doi:10.1126/science.1105511 · Cited by 348
Self-citation
Cited by
Molecular Docking and Structure-Based Drug Design Strategies
Ferreira, L., Dos Santos, R., Oliva, G., & Andricopulo, A. (2015) · Molecules · doi:10.3390/molecules200713384 · Cited by 2,528
Toxicity Testing in the 21st Century: A Vision and a Strategy
Krewski, D., Acosta, D., Andersen, M., Anderson, H., Bailar, J. C., Boekelheide, K., Brent, R., Charnley, G., Cheung, V. G., Green, S., et al. (2010) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2010.483176 · Cited by 1,688
Xu, M., Lee, E. M., Wen, Z., Cheng, Y., Huang, W.-K., Qian, X., TCW, J., Kouznetsova, J., Ogden, S. C., Hammack, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4184 · Cited by 641
Self-citationTransforming Environmental Health Protection
Collins, F. S., Gray, G. M., & Bucher, J. R. (2008) · Science · doi:10.1126/science.1154619 · Cited by 630
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
Improving the Human Hazard Characterization of Chemicals: A Tox21 Update
Tice, R. R., Austin, C. P., Kavlock, R. J., & Bucher, J. R. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1205784 · Cited by 618
Self-citationSingh, A., Venkannagari, S., Oh, K. H., Zhang, Y.-Q., Rohde, J. M., Liu, L., Nimmagadda, S., Sudini, K., Brimacombe, K. R., Gajghate, S., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00651 · Cited by 617
High-throughput screening assays for the identification of chemical probes
Inglese, J., Johnson, R. L., Simeonov, A., Xia, M., Zheng, W., Austin, C. P., & Auld, D. S. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.17 · Cited by 614
Self-citationA PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate
Pacold, M. E., Brimacombe, K. R., Chan, S. H., Rohde, J. M., Lewis, C. A., Swier, L. J. Y. M., Possemato, R., Chen, W. W., Sullivan, L. B., Fiske, B. P., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2070 · Cited by 553
Self-citationWetzel, S., Bon, R. S., Kumar, K., & Waldmann, H. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007004 · Cited by 505
Kavlock, R., Chandler, K., Houck, K., Hunter, S., Judson, R., Kleinstreuer, N., Knudsen, T., Martin, M., Padilla, S., Reif, D., et al. (2012) · Chemical Research in Toxicology · doi:10.1021/tx3000939 · Cited by 494
Big data and artificial intelligence modeling for drug discovery
Zhu, H. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023324 · Cited by 455
“Over the past ten years, this effort has also stimulated the development of high-throughput screening (HTS) techniques (24–26).”
BackgroundApparent activity in high-throughput screening: origins of compound-dependent assay interference
Thorne, N., Auld, D. S., & Inglese, J. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.020 · Cited by 430
Self-citationMaximum Unbiased Validation (MUV) Data Sets for Virtual Screening Based on PubChem Bioactivity Data
Rohrer, S. G., & Baumann, K. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci8002649 · Cited by 402
Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., Nguyen, D.-T., & Austin, C. P. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001862 · Cited by 401
Self-citationNew approaches to molecular cancer therapeutics
Collins, I., & Workman, P. (2006) · Nature Chemical Biology · doi:10.1038/nchembio840 · Cited by 391
Classification of scaffold-hopping approaches
Sun, H., Tawa, G., & Wallqvist, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.024 · Cited by 375
The Scaffold Tree − Visualization of the Scaffold Universe by Hierarchical Scaffold Classification
Schuffenhauer, A., Ertl, P., Roggo, S., Wetzel, S., Koch, M. A., & Waldmann, H. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600338x · Cited by 364
A High-Throughput Screen for Aggregation-Based Inhibition in a Large Compound Library
Feng, B. Y., Simeonov, A., Jadhav, A., Babaoglu, K., Inglese, J., Shoichet, B. K., & Austin, C. P. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061317y · Cited by 358
Self-citationToxicity Testing in the 21st Century: Bringing the Vision to Life
Andersen, M. E., & Krewski, D. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn255 · Cited by 325
Thorne, N., Inglese, J., & Auld, D. S. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.012 · Cited by 315
Self-citationInterpreting steep dose-response curves in early inhibitor discovery.
Shoichet, B. K. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm061103g · Cited by 304
Datta, A., Kim, H., McGee, L., Johnson, A. E., Talwar, S., Marugan, J., Southall, N., Hu, X., Lal, M., Mondal, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26411-7 · Cited by 296
Huang, R., Grishagin, I., Wang, Y., Zhao, T., Greene, J., Obenauer, J. C., Ngan, D., Nguyen, D.-T., Guha, R., Jadhav, A., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00445 · Cited by 294
Self-citationShukla, S. J., Huang, R., Austin, C. P., & Xia, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.07.007 · Cited by 291
Self-citationHigh-resolution dose–response screening using droplet-based microfluidics
Miller, O. J., Harrak, A. E., Mangeat, T., Baret, J.-C., Frenz, L., Debs, B. E., Mayot, E., Samuels, M. L., Rooney, E. K., Dieu, P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113324109 · Cited by 286
Hill coefficients, dose–response curves and allosteric mechanisms
Prinz, H. (2010) · Journal of Chemical Biology · doi:10.1007/s12154-009-0029-3 · Cited by 284
Identification of oxadiazoles as new drug leads for the control of schistosomiasis
Sayed, A. A., Simeonov, A., Thomas, C. J., Inglese, J., Austin, C. P., & Williams, D. L. (2008) · Nature Medicine · doi:10.1038/nm1737 · Cited by 270
Self-citationA selective USP1–UAF1 inhibitor links deubiquitination to DNA damage responses
Liang, Q., Dexheimer, T. S., Zhang, P., Rosenthal, A. S., Villamil, M. A., You, C., Zhang, Q., Chen, J., Ott, C. A., Sun, H., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1455 · Cited by 265
Self-citationFluorescence Spectroscopic Profiling of Compound Libraries
Simeonov, A., Jadhav, A., Thomas, C. J., Wang, Y., Huang, R., Southall, N. T., Shinn, P., Smith, J., Austin, C. P., Auld, D. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701301m · Cited by 262
Self-citationHuang, R., Xia, M., Sakamuru, S., Zhao, J., Shahane, S. A., Attene-Ramos, M., Zhao, T., Austin, C. P., & Simeonov, A. (2016) · Nature Communications · doi:10.1038/ncomms10425 · Cited by 259
Self-citationThe Tox21 robotic platform for the assessment of environmental chemicals – from vision to reality
Attene-Ramos, M. S., Miller, N., Huang, R., Michael, S., Itkin, M., Kavlock, R. J., Austin, C. P., Shinn, P., Simeonov, A., Tice, R. R., et al. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.015 · Cited by 255
Self-citationCompound Cytotoxicity Profiling Using Quantitative High-Throughput Screening
Xia, M., Huang, R., Witt, K. L., Southall, N., Fostel, J., Cho, M.-H., Jadhav, A., Smith, C. S., Inglese, J., Portier, C. J., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10727 · Cited by 255
Self-citationCiallella, H. L., & Zhu, H. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00393 · Cited by 227
“69,70 Automatic data analysis and the application of robots to replace humans in the testing procedures considerably lower the cost of testing a compound and rapidly grow the current big data sources.”
BackgroundOpportunities and challenges in translational science
Austin, C. P. (2021) · Clinical and Translational Science · doi:10.1111/cts.13055 · Cited by 188
Self-citationZhu, H., Zhang, J., Kim, M. T., Boison, A., Sedykh, A., & Moran, K. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500145h · Cited by 154
Comparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction
Russo, D. P., Zorn, K. M., Clark, A. M., Zhu, H., & Ekins, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00546 · Cited by 152
Sedykh, A., Zhu, H., Tang, H., Zhang, L., Richard, A., Rusyn, I., & Tropsha, A. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002476 · Cited by 119
Drug discovery and development for rare genetic disorders
Sun, W., Zheng, W., & Simeonov, A. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38326 · Cited by 107
Self-citationComparative Study of Multitask Toxicity Modeling on a Broad Chemical Space
Sosnin, S., Karlov, D., Tetko, I. V., & Fedorov, M. V. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00685 · Cited by 102
Ipomoeassin F Binds Sec61α to Inhibit Protein Translocation
Zong, G., Hu, Z., O’Keefe, S., Tranter, D., Iannotti, M. J., Baron, L., Hall, B., Corfield, K., Paatero, A. O., Henderson, M. J., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13506 · Cited by 93
Self-citationImproving Phenotypic Measurements in High-Content Imaging Screens
Ando, D. M., McLean, C. Y., & Berndl, M. (2017) · doi:10.1101/161422 · Cited by 96
Harrill, J. A., Freudenrich, T., Wallace, K., Ball, K., Shafer, T. J., & Mundy, W. R. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.04.001 · Cited by 86
Identification of Compounds for Butyrylcholinesterase Inhibition
Li, S., Li, A. J., Travers, J., Xu, T., Sakamuru, S., Klumpp-Thomas, C., Huang, R., & Xia, M. (2021) · SLAS Discovery · doi:10.1177/24725552211030897 · Cited by 60
A Comprehensive Strategy to Discover Inhibitors of the Translesion Synthesis DNA Polymerase κ
Yamanaka, K., Dorjsuren, D., Eoff, R. L., Egli, M., Maloney, D. J., Jadhav, A., Simeonov, A., & Lloyd, R. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045032 · Cited by 35
Self-citationA High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth
Lal-Nag, M., McGee, L., Guha, R., Lengyel, E., Kenny, H. A., & Ferrer, M. (2017) · SLAS Discovery · doi:10.1177/2472555216687082 · Cited by 33
Chen, C. Z., Southall, N., Xiao, J., Marugan, J. J., Ferrer, M., Hu, X., Jones, R. E., Feng, S., Agoulnik, I. U., Zheng, W., et al. (2013) · SLAS Discovery · doi:10.1177/1087057112469406 · Cited by 31
Self-citationSako, M., Yasuo, N., & Sekijima, M. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01385 · Cited by 21
Alagappan, M., Jiang, D., Denko, N., & Koong, A. C. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-26666-4_15 · Cited by 10
Hu, X., Shinn, P., Itkin, Z., Ye, L., Zhang, Y.-Q., Shen, M., Ford-Scheimer, S., & Hall, M. D. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00256 · Cited by 3
Metadata
- Authors
- Inglese, J., Auld, D. S., Jadhav, A., Johnson, R. L., Simeonov, A., Yasgar, A., Zheng, W., & Austin, C. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-08
- Volume
- 103
- Issue
- 31
- Pages
- 11473-11478
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2128879247
- Cited by
- 792
- References
- 22
- FWCI
- 41.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.